Eisai
4523.T
#2229
Rank
C$12.39 B
Marketcap
C$43.93
Share price
-0.46%
Change (1 day)
-9.12%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.22. In 2026 the company made an earnings per share (EPS) of C$1.21 a decrease over its 2025 EPS that were of C$1.53.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026C$1.21-21.04%
2025C$1.5311.85%
2024C$1.37-32.63%
2023C$2.035.52%
2022C$1.93-74.01%
2021C$7.42-66.58%
2020C$22.1998.24%
2019C$11.1917.01%
2018C$9.5637.78%
2017C$6.94-27.62%
2016C$9.5935.33%
2015C$7.09-2.82%
2014C$7.29-27.66%
2013C$10.08-27.49%
2012C$13.90-12.67%
2011C$15.9288.08%
2010C$8.47-11.06%
2009C$9.52-390.15%
2008C-$3.28-127.78%
2007C$11.81347.11%
2006C$2.644.38%
2005C$2.537.4%
2004C$2.3643.03%
2003C$1.6525.09%
2002C$1.3252.67%
2001C$0.8669.76%
2000C$0.51